CG Oncology raises $380M in the first biotech IPO of 2024

The latest stories trending on MedCity News.

Editor's Pick

Top Story Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024 CG Oncology's upsized IPO will support pivotal testing of cretostimogene, an oncolytic virus for non-muscle invasive bladder cancer. The clinical program spans tests of the engineered virus as a monotherapy and as part of combination treatments. Sponsored Content Achieving Operational Improvement Through Improved Awareness Levels Presented by Care Logistics Exceptional awareness levels help hospitals improve operational efficiency and can also help health systems increase capacity, improve access to care, achieve higher profitability and improve margins.  Learn more! Check Out This Pre-Conference Workshop at INVEST 2024 Did you know the U.S. Government funds startups and is a great source for small business support? Chris Sasiela, Director, Innovator SEED Innovator Support Services, from NIH will cover resources and programs available to enhance a portfolio startup's success. Including access to entrepreneurs-in-residence, subject matter experts in regulatory and reimbursement, gap analyses, entrepreneurial training and more. Secure your spot today and save. Register Now for $995 [rate ends Feb 16th]

Featured News

AWS to Infuse Another $20M Into Its Health Equity Program AWS is funneling an additional $20 million into its health equity initiative, bringing the company's total investment in the program to $60 million. As AWS continues to advance the mission of this program, the company is focusing on three main priorities: increasing access to high quality care, building resilient communities, and mitigating the harmful effects of climate change. Key Trends from the 2024 J.P. Morgan Healthcare Conference Key trends such as the resilience of the emerging biopharma space, the complexities of Medicare, and the revolutionary role of data and AI are shaping the future of the industry. Novel Approaches Are Essential for Enabling Patient-First Outcomes in Value Based Care Models Despite the significant challenges to improving U.S. health outcomes while reducing healthcare spending, I am heartened by the exciting ways in which government organizations and the private sector are innovating and deploying new technologies that can achieve these goals. Inside California's Free Digital Health Platforms Supporting Child Mental Health The California Department of Health Care Services launched the Behavioral Health Virtual Services Platform last week. The platform includes two digital health solutions: BrightLife Kids (developed by Brightline) for parents/caregivers and kids ages 0 to 12 and Soluna (developed by Kooth) for teens and young adults ages 13 to 25. INVEST 2024 Is Only 4 Months Away: Here's a Sneak Peek at the Agenda Panel discussions will include investment trends, women's health, value-based care, employer health and more. Startups will also have the opportunity to meet with investors as part of our Ask the Investor program. The conference will be held May 21-22 at the Ritz Carlton in Chicago. Register today!

Resources

MedCity FemFwd: Shortcomings in Menopause Care with Dr. Bruce Dorr In this episode, we were joined by Dr. Bruce Dorr, an OB-GYN and senior medical advisor for Biote, a hormone optimization company. Just about every woman will go through menopause, yet treatment is inadequate. This comes down to the lack of medical training for menopause care, according to Dorr. He discusses why this is and what needs to change. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe